dEsparbes Eric 4
4 · BIORA THERAPEUTICS, INC. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
dEsparbes Eric
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-15+62,225→ 90,365 total - Award
Common Stock
2023-03-15+22,692→ 113,057 total - Tax Payment
Common Stock
2023-03-15$2.56/sh−11,216$28,713→ 101,841 total
Footnotes (3)
- [F1]Consists of 62,225 restricted stock units ("RSUs"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer.
- [F2]Consists of 22,692 RSUs, which vested upon grant.
- [F3]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.